Non-Prescription Medication Dispensing AgreementDispensing Agreement • March 8th, 2009
Please note: Before dispensing any medication, an authorized PTSC staff member will contact the parent, guardian or emergency contact for approval. No medication will be dispensed without this approval.
Dispensing AgreementDispensing Agreement • November 6th, 2018 • Vericel Corp • Biological products, (no disgnostic substances) • Massachusetts
This Dispensing Agreement ("Agreement") is made as July 26, 2018 ("Effective Date") between Vericel Corporation ("Vericel") and AllCare Plus Pharmacy, 50 Bearfoot Rd, Northborough, MA 01532 ("AllCare”).
Non-Prescription Medication Dispensing AgreementDispensing Agreement • August 2nd, 2013
When prescription medication is to be dispensed, I understand that it is my sole responsibility to give medication for my minor child directly to authorized Team Prime Time staff with full instructions in original prescription bottles only. I also understand that it is my sole responsibility to inform Team Prime Time of any changes or modifications in the dispensing of medication. In all cases, I recognize that medication dispensing can only be changed or modified by completing another Prescription Medication Dispensing Agreement.
First Amendment to Dispensing AgreementDispensing Agreement • August 6th, 2019 • Vericel Corp • Biological products, (no disgnostic substances)
This First Amendment to the July 26, 2018 Dispensing Agreement (“Agreement”) between Vericel Corporation and AllCare Plus Pharmacy (“AllCare”) shall be effective as of May 1, 2019 (“Effective Date”).
Fourth Amendment to Dispensing AgreementDispensing Agreement • August 1st, 2024 • Vericel Corp • Biological products, (no disgnostic substances)
This Fourth Amendment to the July 26, 2018 Dispensing Agreement ("Agreement") between Vericel Corporation ("Vericel" or "Client") and AllCare Plus Pharmacy LLC ("AllCare") shall be effective as of June 1, 2024 ("Effective Date").
Physician Dispensing Agreement FormDispensing Agreement • July 18th, 2022
• Please return the completed form with your Application for Registration to Provide Abortion-Inducing Drugs, Form OIG 20-365A, to:
